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Estimating heritability and genetic correlations
from large health datasets in the absence
of genetic data
Gengjie Jia 1, Yu Li 2, Hanxin Zhang 1,3, Ishanu Chattopadhyay1, Anders Boeck Jensen4, David R. Blair5,
Lea Davis 6, Peter N. Robinson 7, Torsten Dahlén8, Søren Brunak9, Mikael Benson 10, Gustaf Edgren 8,
Nancy J. Cox6, Xin Gao 2 & Andrey Rzhetsky 1,3,11*
Typically, estimating genetic parameters, such as disease heritability and between-disease
genetic correlations, demands large datasets containing all relevant phenotypic measures and
detailed knowledge of family relationships or, alternatively, genotypic and phenotypic data for
numerous unrelated individuals. Here, we suggest an alternative, efﬁcient estimation
approach through the construction of two disease metrics from large health datasets: tem-
poral disease prevalence curves and low-dimensional disease embeddings. We present
eleven thousand heritability estimates corresponding to ﬁve study types: twins, traditional
family studies, health records-based family studies, single nucleotide polymorphisms, and
polygenic risk scores. We also compute over six hundred thousand estimates of genetic,
environmental and phenotypic correlations. Furthermore, we ﬁnd that: (1) disease curve
shapes cluster into ﬁve general patterns; (2) early-onset diseases tend to have lower pre-
valence than late-onset diseases (Spearman’s ρ= 0.32, p < 10–16); and (3) the disease onset
age and heritability are negatively correlated (ρ=−0.46, p < 10–16).
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D isease manifestation patterns across populations areinformative in at least two ways: (1) each disease has aunique prevalence proﬁle across a patient’s age and sex,
and (2) diseases co-occur in nonrandom sequences. Firstly,
geneticists and physicians have long been aware of the differences
between early- and late-onset forms of the same disease. Earlier-
onset disease subtypes have been typically associated with severer
symptoms and higher heritability1,2. However, this late-versus-
early-onset logic does not generalize well across diseases—with
notable exceptions. Huntington’s disease, for example, has a
relatively late onset, typically, during the third or fourth decade of
a patient’s life, but it is a Mendelian, highly heritable condition.
Secondly, physicians appreciate and occasionally use the infor-
mation from a patient’s chronological disease sequence to assist
in disease diagnosis and management3. Given the richness of
information contained in these disease trend and comorbidity
patterns, we hypothesized that they could be useful in dissecting
the genetic and environmental determinants of pathogenesis.
Traditionally, there are three main approaches to estimate
quantitative genetic parameters like heritability and genetic cor-
relations, all of which require the same two inputs: (1) genetic
information (e.g., relatedness or genetic variants), and (2) phe-
notypic information (the affected or unaffected status with
respect to one or more diseases).
The simplest and most intuitive way of computing these
quantities involves a comparison of disease pattern concordance
among monozygotic and dizygotic twins4,5. Monozygotic twins
are genetically identical and dizygotic twins share, on average,
half of their genetic polymorphisms. Therefore, it is relatively easy
to mathematically partition the genetic and shared environmental
contributions to disease phenotypes.
A slightly more complex version of the same approach involves
an analysis of the overall nuclear family phenotypic variance of
parents and children6. Because parents are typically genetically
unrelated, a parent and a child share with each other half of their
genetic variants, as do siblings. One can mathematically subdivide
the overall phenotypic variance into several components (genetic,
individual environment, shared sibling environment, and shared
couple environment).
Building on more modern technology, an orthogonal approach
to estimating heritability and genetic correlations utilizes genome-
wide association studies (GWASs) outputs. In this approach,
numerous unrelated individuals are compared in terms of their
single-nucleotide polymorphisms (SNPs). The SNP-heritability is
estimated as a proportion of the overall phenotypic variance
explained by the common genetic polymorphisms of the affected
individuals7,8. In particular, when estimates are computed using
effect-size summation over SNPs, we refer to this version of
heritability estimate as based on a polygenic risk score (PRS)9,10.
The recent increase of both the importance and the availability
of electronic health records (EHRs) has allowed us to scale family
based analyses to millions of people11,12. However, methodologi-
cally, the procedure has not evolved much since the ﬁrst family
studies were performed. As a rule, EHRs are maintained in order
to facilitate patient billing rather than academic research, and
therefore, they are generally incomplete and biased13. However,
this does not diminish their overall utility for making accurate
inferences about clinical phenotypes in large populations. For
example, administrative data has been successfully used to study
asthma14, autism15, brain metastases16, colonoscopy ﬁndings17,18,
colorectal and breast cancers19, depression20, glomerular ﬁltration
rate21, polypectomy22, and rheumatoid arthritis23 in various
populations. Furthermore, statistical epidemiologists routinely
analyze insurance data to test for potential causal relationships
between environmental factors and human maladies—for exam-
ple, the effects of psychiatric pharmaceuticals on suicide rates24.
The key to these types of analysis is to carefully examine how
missing data and biases may affect the intended conclusions of the
research and, if required, how to introduce appropriate, bias-
neutralizing corrections13.
The accumulating legacy estimates of genetic parameters, such
as heritability and genetic correlations, pave way for the fourth
approach that we are proposing here. Leveraging national EHR
databases from the United States, Denmark and Sweden, we show
that disease-speciﬁc statistics can be used to estimate heritability
(h2), inter-disease genetic/environmental/phenotypic correlations
(corr) with an accuracy comparable to traditional clinical studies.
These added estimates lead us to the ﬁndings that disease onset
age is positively correlated with disease prevalence, but is nega-
tively correlated with disease heritability.
Results
Deﬁning and computing disease prevalence curves. To capture
the distribution of disease prevalence across age and sex, we
computed disease prevalence curves by dividing the total number
of disease codes (ICD codes) within each age-sex stratum by
the number of enrolled patients matching these demographics
(see Methods part 1 for the precise deﬁnitions). A disease pre-
valence curve’s shape reﬂects the multiplicity of age-speciﬁc
landmark events in a patient’s life, ranging from health-neutral
medical checkups (which can nevertheless reveal underlying
conditions), to age-speciﬁc hormonal changes (e.g., puberty,
pregnancy, or menopause), and to traumas and infections that
may also correlate with age. Despite the existence of some
country-speciﬁc variations (for example, in bipolar disorder,
rheumatoid arthritis, and depression, see Fig. 1a), the curve
shapes are rather consistent across countries for a large set of
diseases, (see autism and gastrointestinal infection curves, and
Supplementary Fig. 1 for selected examples, which were ﬁrst
discovered using the US25 and Danish26 cohorts, and then vali-
dated using the Swedish data27,28).
To further investigate shape-of-curve similarity, we deﬁned a
symmetric distance measure (see Methods part 2 for analytical
details; Fig. 1b showing the full dissimilarity matrix). Our
comparison across the whole disease spectrum and two countries
(US and Denmark) identiﬁed ﬁve clusters (see Supplementary
Fig. 2 for model selection results and Supplementary Data 7 for
the complete list of over 500 studied diseases), and they have very
distinct disease category, sex, and country compositions (Fig. 1c).
For example, the smaller Clusters 4 and 5 primarily comprise
neoplastic and developmental diseases, respectively. In these two
clusters, the proportions of Denmark-derived disease curves are
larger than US-derived ones. In contrast, US-derived curves are
more common in Cluster 3. These clusters correspond to distinct
shapes of curves: Cluster 1 corresponds to L-shaped early-onset
conditions; Clusters 2 and 4 include reversed L-shaped curves
(the former being early but slow rising, while the latter being
later- but steeper-rising); Cluster 3 is the only multi-modal curve
shape type; and Cluster 5 presents a skewed bell shape with a less
heavy right tail than that of Cluster 1. For each cluster, we show a
few representative disease curve alignments across different
categories (indicated below in brackets). For example, in Cluster
1, parasitic infection aligns with an array of noninfectious
diseases, including neuroﬁbromatosis (hereditary and neoplastic),
tympanic membrane disorders (otic), osteogenesis imperfecta
(hereditary and musculoskeletal), and congenital eye anomaly
(developmental). To the best of our knowledge, disease curves,
standardized across age and sex, have never previously been
systematically compared. The discovered resemblance, which can
be of great interest to researchers and physicians, likely reﬂects a
combination of shared factors in genetics (e.g., among autism,
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conduct disorder, tics, and Tourette syndrome29), environmental
exposures, and developmental triggers (onset of puberty or
menopause), or even direct causal links.
Deﬁning and computing disease embeddings. To further aug-
ment disease similarity descriptors for this imputation procedure,
we implemented a disease embedding approach30–32, inspired by
natural language processing. To construct an embedding, we used
a neural network as the mathematical representation of a word’s
underlying semantics, given its surrounding words (Methods part
3). The intuition behind this method is that semantically-similar
words likely share contexts and would thus be encoded by similar
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vectors of continuous parameters learned by a neural network. By
analogy, chronologically ordered diseases in a patient’s health
record are “words,” while the entire historical record becomes a
“sentence.” We employed over 151 million unique patient his-
tories to compute the embedding for over 500 major diseases
within a 20-dimensional continuous space, in which each disease
is represented by a 20-dimensional vector (see Fig. 2 for snap-
shots of 3-dimensional projections of the embedding). To make
our choice of dimensionality for the embedding space, we were
driven by the following considerations: (1) the space dimen-
sionality should be much smaller than the “vocabulary” size (over
500 in our case), but also be reasonably large enough to ensure
adequate predictive power, and (2) the disease embedding with 20
latent dimensions should generate a reasonable nosology, as
judged by physicians in our team. We further compiled a col-
lection of published parameter estimates, including 1146 h2
estimates and 1947 various corr estimates (see Supplementary
Data 1 and 2, respectively).
Building estimators from disease descriptors. Disease pre-
valence curves and disease embeddings derived from the US
dataset were used as disease-speciﬁc descriptors for modeling. The
modeling features also included speciﬁcations about predicted
estimates (data type and mathematical model used), basic infor-
mation about the investigated cohorts (country of origin and sex),
and disease characteristics (category of biological systems that the
disease belongs to, and the onset age). A detailed description of
disease features used in the model can be found in Methods part 4.
Equipped with various descriptors for individual diseases,
disease–disease similarity measures, and large collections of legacy
heritability and inter-disease correlation estimates, we proceeded
to estimate missing genetic parameters across the whole pathology
spectrum (see Fig. 3a for the outline of our modeling framework,
and Fig. 3b–d for full collection of results). We tested a battery of
modeling approaches, out of which a gradient boosting regression
performed the best33–35 (see Table 1 and Methods part 7 for
details). As a measure of estimate quality, we used Pearson’s
correlation between imputed values and “actual” parameter values,
training the ensemble regression model on 80% of the data and
testing it on a held-out 20%. To ensure that results were not biased
by a single lucky data split, we repeated this computation for 1000
randomly partitioned datasets.
Contour plots in Fig. 3b, c show the joint distributions of model
predicted and previously published estimates: in the case of h2, the
density peaked around (0, 0) and (0.4, 0.4), indicating denser
collocations of published and predicted estimates there; while as
for corr, the estimates exhibited a unimodal distribution with a
peak close to (0.05, 0.05). The slopes of both linear regressions
were close to 1, with negligible intercepts, indicating that our
estimates were nearly perfectly unbiased. The correlations between
our predictions and the corresponding legacy estimates had means
of 0.870 ± 0.001 (95% conﬁdence interval computed based on
1000 replicates) for h2 and 0.874 ± 0.001 for corr (Fig. 3d). As
shown in Supplementary Table 1, over 40% of the useful
information is from disease prevalence curves, over 30% from
disease embeddings, and the rest mostly attributable to data types
and mathematical models used in the relevant published studies. A
detailed breakdown of the contribution of the 20 embedding
factors shows that all the 20 factors contribute nearly equally.
To evaluate if our estimators were reasonably accurate, we
computed a measure of agreement among previously published h2
estimates. For this comparison, we used only published,
independent estimates, matched both by data type and estimation
methodology (if there were more than two estimates of the same
type, we used all of them, generating all possible comparison
pairs). We obtained 205 pairs of estimates in total and computed a
Pearson’s correlation value of 0.51, Student’s t test p= 3.5 × 10−15
(Supplementary Fig. 3a); agreement among these past estimates
was much lower than what we observed for our estimates.
Furthermore, the comparison between our estimates and very
recently published sets of estimates12 (which were used in neither
training nor validation in our analysis) showed a signiﬁcantly
higher concordance between the two sets of estimates than legacy
data (Pearson’s correlation 0.71, Student’s t test p= 4.8 × 10−22,
the number of estimates for comparison= 136; see Supplementary
Fig. 3b and Supplementary Data 3 for comparison details).
Similarly, to assess the accuracy of correlation estimates, we were
able to identify an additional, independent dataset of genetic
correlations36 and reserved it exclusively for testing purposes. This
test dataset was generated in context of GWASs and using a
linkage disequilibrium score (LDSC) regression, we compared our
predictions for the same data type and mathematical method. This
conﬁrmed a signiﬁcantly high concordance (Pearson’s correlation
= 0.73, Student’s t test p= 1.7 × 10−14, the number of estimates
for comparison= 80; please see Supplementary Fig. 3d and
Supplementary Data 5 for comparison details). We therefore
cautiously claim that our estimates are at least as good as those
computed with traditional methods.
The addition of numerous genetic parameter estimates helped
to statistically empower our downstream ﬁndings.
Properties of disease heritability estimates. Our initial analysis
of US medical data generated a curious ﬁnding: The apparent
overabundance of diseases with early onset. The distribution over
Fig. 1 Disease prevalence curves fall into ﬁve major shape clusters. a Representative disease prevalence curves for neurodevelopmental, psychiatric,
infectious, inﬂammatory, autoimmune, and some miscellaneous diseases; we show disease names at the top of the corresponding plot. A curve’s x-axis
corresponds to the age of diagnoses (not necessarily the ﬁrst one in the patient’s recorded health trajectory), and the y-axis denotes the relative prevalence
of each diagnosis in the corresponding age and sex group. For ease of comparison across countries, we re-normalized each curve to sum to 1. We
computed the curves for two countries: the US and Denmark. US male-speciﬁc curves are depicted with blue-dotted lines and female-speciﬁc ones with red
solid lines. As for their Danish counterparts, male-speciﬁc curves are shown with green-dotted lines and female-speciﬁc ones with purple solid lines. Each
curve is supplied with a 99% conﬁdence interval (in transparent colors). We ﬁnd that some disease curves are consistent across countries and sexes (e.g.,
autism and gastrointestinal infection), while others vary by country only (e.g., bipolar disorder and rheumatoid arthritis), and still others vary by sex only
(e.g., osteoporosis and Crohn’s disease). b A distance matrix, shown as a heatmap, represents the shape dissimilarity between curves measured via the
Jensen-Shannon divergence (Methods part 2). We applied a hierarchical clustering algorithm and elbow model selection to arrive at a ﬁve-cluster
classiﬁcation of curve shapes; the ﬁve clusters, c1–c5, are shown in red, yellow, green, blue, and purple, respectively. c At the left side of the plate, three
columns of stacked bar charts summarize the compositions of each cluster in terms of disease category, sex, and country. At the right side of the plate, we
show the optimal curve alignments (after relative shifts along the x-axis) of several representative diseases from each cluster. For each disease, we
computed variations across four prevalence curve instances (two countries by two sexes), showing the curve mean and variation as a solid line and a
shaded same-color area, respectively. The optimal relative shifts for the alignment are written as bracketed integer numbers (in years) after each
disease name.
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the mean age of ﬁrst disease diagnosis is approximately bell-
shaped but skewed towards younger ages, with onset age mode
around 42 years over all diseases (Fig. 3e). The total number of
disease assignments is positively correlated with disease onset age
(see Methods part 1 for the precise deﬁnition; Spearman’s cor-
relation is ρ= 0.32, p < 10−16 computed using algorithm AS 89
(refs. 37,38), as shown in Fig. 3f), and individual shape clusters all
agree on the positive correlation (Methods part 5, Fig. 3g, and
Supplementary Table 2). This observation suggests that early-
onset diseases outnumber late-onset diseases in the human
population, and the former tend to have lower prevalence. Pos-
sible explanations for this could be associated with: (1) current
clinical practice, such as routine newborn screening and mon-
itoring, generating an overabundance of early-life health obser-
vations; (2) a tendency for conditions with substantial genetic
etiology to have an earlier onset age while simultaneously being
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Fig. 2 An embedding disease mapping into metric space positions, with related diseases close to each other. Diseases can be mapped to points in low-
dimensional metric space (so-called “disease embedding”). See the three-dimensional projections of our 20-dimensional embedding in (a)–(d) in this
ﬁgure, where similar diseases are closer to each other in metric space than dissimilar ones. This 20-dimensional disease embedding turned out to be
extremely useful in this study for estimating population-genetics parameters for individual diseases. a We projected the 20-dimensional disease
embedding vectors of over 500 diseases into 3-dimensional space for ease of visualization, using the t-SNE algorithm52. We color-coded the spheres
representing the diseases by each corresponding disease category. Plate b shows Mendelian vs. non-Mendelian disease distribution. Plate c shows disease-
speciﬁc sex bias (deﬁned in such a way that it is 0 for diseases that are equally frequent in males and females, −0.5 for diseases that occur only in females,
and +0.5 for those occurring only in males). Plate d shows diseases color-coded in accordance with their onset ages, where green colors indicate early-
onset childhood diseases, and warmer colors point to later-onset diseases.
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driven to lower prevalence through negative selection; and (3) a
historical bias in biomedical discovery since early-onset diseases
were easier to document and categorize.
Because hypotheses (1) and (3) mentioned above cannot be
tested with the data currently available to us, we focused ﬁrst on
hypothesis (2) and sought evidence of a systemically increased
genetic load among early-onset diseases, using a narrow-sense
heritability. The relevant legacy estimates were sparse (Fig. 4a and
Supplementary Fig. 4a plot the twin/family and SNP/PRS-type
estimates, respectively, against disease onset age). This study’s
imputation analysis added about 800 estimates to twin/family and
SNP/PRS-type heritability estimates. The overall linear relation-
ship between onset age and heritability was signiﬁcantly,
negatively sloped (Fig. 4a, b and Supplementary Fig. 4b).
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Fig. 3 Estimating population-genetics parameters for hundreds of diseases and thousands of disease pairs. Here, h2 denotes heritability, and corr is a
correlation between a disease pair which can be genetic, environmental, or phenotypic. a A workﬂow explains the key steps of our model development. We
used three national-scale health registries, representing the United States, Denmark, and Sweden, which comprised 3.8 billion, 154 million, and 95 million
disease diagnoses, respectively. We computed curves reﬂecting disease prevalence by age and sex (disease prevalence curves) and derived a metric
mapping (disease embedding in metric space) for the whole disease spectrum. We used these two complementary representations to estimate hundreds
of thousands of disease-speciﬁc parameters. We then validated the accuracy of our model’s predictions by benchmarking them against previously-
published (“actual”) estimates that were not used in model training. Plates b and c show kernel density estimation plots we computed from 1000 random
4:1 splits of data (4/5 for training and 1/5 for testing). We used these plots to visualize the joint distribution of the actual data for testing and model-
predicted values. The linear ﬁt slopes between the actual and predicted values are 0.996 for h2 and 0.993 for corr, indicating nearly perfectly unbiased
estimations. d The distributions of Pearson’s correlations between the actual and predicted values have mean values of 0.870 for h2 and 0.874 for corr. e A
distribution of the mean age of disease-speciﬁc diagnosis bearers. The median of the mean ages over all diseases is around 42 years, and speciﬁcally, the
mean ages of autism, bipolar disorder, and schizophrenia that appeared in the US data are 9, 40, and 41, respectively. f There is a signiﬁcant positive
correlation between disease onset age and diagnosis count in the US data, suggesting there are less-than-expected, rare, late-onset diseases. g The
relationship also holds for each of the ﬁve disease clusters. For individual clusters (c1–c5), we show the best linear approximation, regression coefﬁcients
(p values were computed using Student’s t test), and Spearman’s correlation ρ (p values were computed using algorithm AS 89), color-coded by the shape
cluster. Superscript asterisks indicate signiﬁcance level of the estimates being different from 0.
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Table 1 Performance comparison of different modeling algorithms.
Modeling algorithms 95% CI of Pearson’s γ for h2 prediction 95% CI of Pearson’s γ for corr prediction
Kernel Ridge regression 0.837 ± 0.001 0.867 ± 0.001
Lasso 0.823 ± 0.002 0.793 ± 0.001
Huber regression 0.827 ± 0.001. 0.787 ± 0.001
Ridge regression 0.826 ± 0.001 0.795 ± 0.001
Random forest 0.854 ± 0.001. 0.856 ± 0.001
Support vector regression 0.856 ± 0.001 0.808 ± 0.001
AdaBoost random forest 0.858 ± 0.001 0.858 ± 0.001
Gradient boosting regression 0.870 ± 0.001 0.874 ± 0.001.
Significance codes for p-value: 0 ‘ *** ’ 0.001 ‘ ** ’ 0.01 ‘ * ’ 0.05 ‘. ’ 0.1 ‘   ’ 1   
a Published estimates only b
c
rg
re
0.2
0.4
0.6
0.8
d
0
0.2
0.4
0.6
–0.2
0
0.2
0.4
0.6
0.2
0.4
0.6
0.8
Disease onset age
Tw
in
/fa
m
ily
-ty
pe
 h
2
Dsoc
Dsoc
c1
c2
c3
c4
c5
0 10 20 30 40 50
Disease onset age
0 10 20 30 40 50
Disease onset age
0 10 20 30 40 50
0.2
0.4
0.6
0.8
1.0
Tw
in
/fa
m
ily
-ty
pe
 h
2  
0.2
0.4
0.6
0.8
1.0
Tw
in
/fa
m
ily
-ty
pe
 h
2  
0.2
0.4
0.6
0.8
1.0
Published and model-inferred estimates
Published and model-inferred estimates
 = –0.44*** ; n = 93
100 y = –0.64*** x + 57***
 = –0.11
100 y = –0.69* x + 54***
 = 0.23
100 y = 0.58 x + 12
 = –0.097
100 y = –0.61 x + 62***
 = –0.25***
100 y = –0.38*** x + 48***
 = –0.25***
100 y = –0.36*** x + 50***
 = –0.46*** ; n = 884
100 y = –0.42*** x + 51***
Dsoc = 0.41***rg –0.30***re –0.52***rg.re + 0.27***
Fig. 4 Analyses empowered by our estimates of heritability (h2), and genetic and environmental correlations (rg and re). Plate a includes analyses solely
based on the previously published estimates of twin/family-type h2, suggesting a signiﬁcantly negative correlation between disease onset age and
heritability. b Our estimator substantially enriched the collection of twin/family-type h2 estimates, ﬁlling in numerous missing estimates for under-studied
diseases. When we analyzed disease prevalence curves jointly, we found a signiﬁcantly negative correlation between disease onset age and h2, which also
holds for h2 estimates based on other data types, such as SNP/PRS-type (Supplementary Fig. 4b). c We performed the same analysis for diseases within
each of the ﬁve curve shape clusters, also conﬁrming the signiﬁcantly negative correlations for shape Clusters 1–3. In the smaller Clusters 4 and 5, the
correlations were not signiﬁcant (Methods part 5). d To understand the relationship between a disease pair’s dissimilarity of disease prevalence curves
(Dsoc), and the rg and re for the same disease pair, we performed a regression analysis, expressing Dsoc as a function of rg, re, and an interaction term rg·re (p
values were computed using Student’s t test, see Methods part 6). The corresponding regression coefﬁcients turned out to be 0.41, −0.30, and −0.52,
respectively. This regression analysis suggests the following: When two diseases have only high genetic correlation, their prevalence curves are likely to be
very different; if only environmental correlation is high, the prevalence curves tend to be much more similar. However, disease prevalence curves are most
similar when both environmental and genetic correlations between the two diseases are high. The included disease pairs across all categories are
represented as hundreds of thousands of data points in the plot and they are colored according to the Dsoc values. We also repeated the same Dsoc
regression analysis with all disease pairs from distinct disease categories (see Supplementary Data 6 and Supplementary Fig. 5).
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However, when examined individually, the ﬁve-disease preva-
lence curve shape clusters exhibited heterogeneous behavior
(Methods part 5, Fig. 4c, and Supplementary Fig. 4c). The
detailed results from this analysis are provided in Supplementary
Table 3.
Second, we asked, what can disease prevalence curve similarity
tell us about the interplay between the genetic and environmental
causes39,40 for two diseases? A simple way to interpret the way in
which nature and nurture affect the temporally manifested pattern
of two diseases, is to perform a regression of dissimilarity between
shapes of curves, Dsoc, and genetic (rg), and environmental (re)
correlations between two diseases (Methods part 6, Fig. 4d, and
Supplementary Data 6). The best-ﬁtting regression curve appeared
to be given by equation Dsoc= 0.27+ 0.41rg− 0.30re− 0.52rgre,
where all regression parameters were signiﬁcantly different from
zero (Student’s t test, the largest p= 3.6 × 10−8). What this
equation conveyed to us can be summarized as follows: when two
diseases have only high genetic correlation, their prevalence curves
are likely to be very different; if only environmental correlation is
high, the prevalence curves would be much more similar.
However, disease prevalence curves are most similar when both
environmental and genetic correlations between the two diseases
are high.
Discussion
In addition to rigorously testing the hypotheses central to this
study (the correlation between age of onset and disease herit-
ability), we formulated a number of conjectures that await con-
ﬁrmation elsewhere, such as the link between similar disease curve
shapes and hypothetically similar disease etiology. This study is
intended to stimulate discussion and new thinking about factors
affecting disease curve shapes and disease embedding properties.
We hope that an approach like the one suggested here can
eventually help to elucidate pathogenic mechanisms of common,
complex disease, where genetic predisposition interacts with
speciﬁc environmental insults to produce common disease
symptoms.
We aimed to impute genetic parameter values for diseases in a
gender-, data type- and model-speciﬁc manner in the absence of
genetic data. Our main hypothesis in this quest was that this goal
could be achieved by leveraging country-scale disease comparison
information (prevalence curves and embeddings introduced in
this study) and proper mathematical modeling. This hypothesis
appears to be supported by the data we present in this study.
To understand the contribution made by various predictive
features to our estimator’s quality, it was useful to compute the
relative importance of the disease-speciﬁc features as compared to
that of all features used in the analyses. Our computations show
that curve- and embedding-related disease features contribute
heavily to the quality of the estimate of h2 with 44.6% and 36.8%,
respectively, and 81.4% collectively. Therefore, our newly engi-
neered disease comparison features provide an essential con-
tribution to overall prediction quality. Note that while our training
cohorts come from 23 countries, our feature importance analysis
shows that the predictor about the country of cohort contributes
only 3.7% to the overall prediction quality for h2 values. In other
words, disease heritability estimates appear largely universal, not
signiﬁcantly affected by variation across populations.
We were very selective when including diseases into our pre-
diction set; we only attempted estimations for diseases that were
reasonably covered in the training dataset in the ﬁrst place. For
instance, because the majority of previous studies about genetic
correlation estimation were either based on EHR-inferred pedi-
gree information combined with the ACE (additive genetics,
common environment, and unique environment) model, or SNP-
based combined with the LDSC regression model, we limited our
prediction outputs to these two settings exclusively.
The power of our designed disease features (curves and
embeddings) is rooted in their deep connection to the genetic and
environmental etiology of human pathology. Disease curves are
shaped by a complex superposition of genetic predispositions,
human physiological milestones (such as hormonal changes),
social norms and incentives (such as youth participation in ath-
letic activities), and environmental inﬂuences (exposure to peri-
odic infections, pollution, traumas, and medications). Disease
embeddings capture a disease “synonymy” that is also highly
dependent on cultural and environmental conditions.
The culture-speciﬁc variations that inﬂuence disease prevalence
become especially clear when we think of infectious diseases. A
vivid, if gruesome, example is associated with Kuru, a fatal disease
endemic to the eastern New Guinea Highlands. After a long
search for infectious agents, the disease was linked to prions
transmitted between people via an act of ritual funeral canni-
balism41. There are many other less exotic examples, involving
tropical infections (Ebola, Marburg, yellow fewer), seasonal
infections (stomach and seasonal inﬂuenza), and arthropod-
borne diseases (Lime disease, trypanosomiasis, and sickle cell
disease). Not limited to infectious diseases, for example, there are
rare psychiatric conditions, such as Koro (irrational perception of
imminent loss of genitalia) in Southeast Asia42. Even diseases that
are widely shared by nearly all cultures still have culture-speciﬁc
variations in symptomatology and onset timing43, and even vary
within same-country sub-cultures44. It would be really fascinating
to perform a systematic comparison of disease curves across
numerous cultures and countries. Unfortunately, such compara-
tive analyses are not feasible yet due to the lack of the required
pan-cultural and pan-ethnic data.
Epidemiological literature has devoted considerable attention
to disease variation across sexes and disease onset timing by
focusing on one disease at a time. Investigators have looked at
early-onset schizophrenia45, concluding that the disease-to-sex
ratio does not help to distinguish properties of early- and late-
onset phenotypes. Both phenotypes present similar symptoms,
with some developmental variation; delusions are less complex in
children and are reﬂective of childhood themes. As for asthma,
researchers studied the sub-forms associated with its onset time,
and concluded that the early disease onset is associated with
parental histories of allergy and asthma, genetic predisposition,
and early-life environmental stresses, such as maternal smoking
in pregnancy46. Gender was reported to play an important role in
asthma as well; in females, asthma appears to be predominantly
adult onset rather than pediatric47. More generally, investigators
suggested that, in asthma, disease onset age determines distinct
disease sub-types in adults48. Our study, based on nation-scale
datasets, complements these traditional approaches by system-
atically comparing a diverse set of maladies using the concept of
disease curves. Unlike traditional studies, we looked at a broad
variety of diseases and have suggested that seemingly unrelated
maladies show starkly similar disease curves, which might suggest
a partially shared etiology.
A disease curve documents statistically signiﬁcant changes in a
malady’s prevalence over the average lifespan. From a curve’s
extrema and inﬂections, one can identify patient ages that cor-
respond to apparently distinct disease types. Then, for a given sex
and age, one can search for under- and over-represented events in
the lives of millions of patients. Some of the environmental
trigger events for selected diseases are known, such as puberty,
trauma, changes in dietary habits, and an interaction with a
pathogen-rich environment. Apparent disagreements in sex-
speciﬁc curves for the same disease, such as the presence of a
curve extrema in females that is absent in males, may point to
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previously ignored or as-yet undiscovered causes affecting the
health of the population. A disease curve allows researchers to
focus on relatively narrow, age- and sex-speciﬁc factor subsets
associated with a given disease. With this narrowed collection of
candidate factors, one can further test for their statistical asso-
ciation with a disease in an independent population of patients.
The reader may wonder whether acute and chronic diseases
have distinct properties in terms of genetic parameter estimation
quality? To answer this question, we performed a comparison of
those acute and chronic diseases seen in the test dataset (see
Supplementary Data 4). We ﬁrst computed absolute errors (the
absolute difference between inferred and published values), and
then used a Wilcoxon rank sum test to determine whether the
error distribution seen in acute diseases is different from that seen
in chronic diseases. This difference proved to be nonsigniﬁcant
(p= 0.18, Supplementary Fig. 3c), suggesting that the model
prediction accuracy for acute diseases was not different from that
for chronic ones. Both very much beneﬁt from the rich infor-
mation contained in disease trends and comorbidity patterns,
which makes dissecting the genetic and environmental determi-
nants of their pathogenesis possible. This observation might also
be understood in context of the realization that the distinction
between chronic and acute diseases is artiﬁcial in many cases. For
example, a hemorrhagic stroke is an acute disease that is preceded
by a chronic worsening of cardiovascular health and weakening
blood vessel walls, resulting in a catastrophic (acute) rupture of a
blood vessel (stroke). We conjecture that the heritability of the
chronic stage of vessel weakening should be very similar to the
acute stroke outcome.
To summarize, we computed two types of disease metrics,
covering all human nosology categories. These metrics enabled us
to: (1) impute genetic parameters for hundreds of diseases and
thousands of disease pairs; (2) systematically analyze the rela-
tionship between heritability and disease onset age; and (3) relate
shape-of-curve dissimilarity to genetic and environmental cor-
relations between diseases. In addition, we provide a searchable
web resource including all sex- and country-speciﬁc disease
prevalence curves for over 500 diseases (see the link to the
resource in Data Availability).
Methods
Disease prevalence curve. In analysis A, applied only to the US dataset, we
counted only a single disease diagnosis code per patient per year. We looked at ages
between 0 and 65 years, inclusive; this age limit was imposed by the US MarketScan
enrollment composition. To normalize these raw counts by recorded patients, we
divided this sum of unique (per patient, per age) disease occurrences per year in a
given sex-and-age group by the total number of visible patients in that demo-
graphic group. (To give an example, imagine a hypothetical patient, visible in the
data for 2 years. The ﬁrst year of visibility in the data is at age 35, wherein she has
three diagnosis codes of disease X, and in the second year of visibility, at age 36, she
has seven disease X diagnosis codes. To compute the disease curve, we counted this
patient once in females with X-disease, age 35, and once in females with X-disease,
age 36. We normalized each number by the total number of female enrollees at the
corresponding age, so this hypothetical patient was counted once among enrollees
of age 35, and once among enrollees of age 36.) This analysis implies that we were
estimating, for each point of the curve, the expected proportion of patients in the
speciﬁc sex and age group who will carry the current disease diagnosis. To convert
the curve into a probability distribution, we normalized the raw estimates to
sum to 1.
We designed this analysis in order to infer disease onset age, deﬁned as the
maximum age among the 5% of the youngest patients carrying the disease (i.e., the
age at which the inverse distribution function for the disease curve is 0.05).
In analysis B, we did not use enrollment data (it was not available to us for the
Scandinavian datasets). Instead, we estimated the expected share of disease X in a
given demographic group. In other words, for each disease, we computed the total
number of disease diagnoses in the sex-and-age group and normalized it by the
sum of all disease diagnosis codes in this group. We further re-normalized the
disease curves to sum to 1 to enable the curve comparisons across countries.
We applied this procedure repeatedly to compute curves for all the diseases
recorded in the databases (see Supplementary Data 7 for the complete list) and for
all the combinations of sex-and-country groups (see the searchable web database
https://gjia.shinyapps.io/disease_curves/). Two national-level electronic medical
record datasets were employed as discovery cohorts: one from the Truven Health
Analytics MarketScan Commercial Claims and Encounters Database in the United
States for the years from 2003 to 2013 (ref. 25), and the other from the Danish
National Patient Registry covering the years from 1994 to 2014 (ref. 26) (Fig. 1). For
the purpose of validation, we introduced another independent dataset, the Swedish
National Health Registry, which covers the entire Swedish population’s inpatient
visits between 1968 and 2011 (refs. 27,28) (Supplementary Fig. 1).
Furthermore, we use the US dataset to show that: (1) it is well representative of
the general US population (Supplementary Fig. 6); (2) the curve computation is
robust to variation in modeling hyperparameters, such as the enrollment year
(Supplementary Fig. 7); and (3) the curves are also robust in their general
properties for early-onset conditions, when computed exclusively from the
newborn subpopulation (Supplementary Fig. 8).
Clustering disease prevalence curve shapes. Clustering analysis was based on
US and Denmark datasets, and we arrived at the ﬁve-cluster curve classiﬁcation
shown in Fig. 1b using the following steps:
1. For each curve pair, we computed and minimized its dissimilarity measure
by shifting one curve with respect to the other along the x-axis. We have
chosen the Jensen–Shannon divergence49, introduced for measuring
dissimilarity between two probability distributions. We shifted one curve
with respect to the other one along the x-axis (a year at a time, trying −8 to
+8-year shifts).
2. We repeated this computation for all possible sex-and-country-speciﬁc
curve pairs, covering over 500 human maladies (see the heatmap
representation of dissimilarity matrix in Fig. 1b).
3. Based on this matrix, we applied a hierarchical, clustering algorithm (a
complete linkage method)50 and computed a bottom-up cluster hierarchy.
4. Finally, to determine the optimal number of groups (clusters) with the elbow
model selection method, we used the following steps:
a. Assuming that the optimum cluster number is equal to K (K= 1, 2, …),
we measured the clustering compactness by total intra-cluster variation,
deﬁned as
PK
k¼1
P
xi2Ck ðxi  μkÞ
2, where xi is a data point belonging to
cluster Ck, and μk is the average of the data points in Ck.
b. We computed the total intra-cluster variation repeatedly for different
values of K ranging from 1 to 25 and plotted these values against the
total number of clusters (Supplementary Fig. 2).
c. The location in the plot at which the decline of the total variation
switches from fast to slow (the elbow location) is regarded as the
indicator of the optimal cluster number. In this study, this optimal
number is ﬁve (indicated by a dashed line in Supplementary Fig. 2).
Disease embedding. We used the word2vec algorithm31,32, which was originally
developed for natural language processing. In our implementation, we adjusted the
algorithm in the following ways: (1) we used disease codes in place of natural
language words; (2) we replaced sentences with a chronological sequence of
patient-speciﬁc disease codes; and (3) we replaced the text corpus with a large
collection of patient-speciﬁc diagnostic histories. In a typical word2vec output,
words are mapped into a continuous semantic space, so that synonymous words
are placed nearby. Therefore, we aimed to ﬁnd a similarity-based disease repre-
sentation. The formal goal of this algorithm is to build a real-valued vector
representation for a disease ω in order to predict its context (co-occurring) diseases
ω− given the current disease and vice versa. Using the logarithm of likelihood, L,
the cost function can be expressed as
cost ¼ L ¼ 
X
ω2C
logP ωjωð Þ; ð1Þ
where C represents our “corpus” of over 151 million unique patient histories for
over 500 major diseases. We used this corpus to train a neural network model using
the gensim package30. We used context size of eight disease codes.
As a result, each disease is represented by a 20-dimensional vector (see Fig. 2 for
snapshots of 3-dimensional projections of the embedding). We justify our choice of
dimensionality for embedding space by the following considerations: (1) the space
dimensionality should be much smaller than the “vocabulary” size (over 500
disease types in our case), but also be reasonably large enough to ensure adequate
predictive power, and (2) the disease embedding with 20 latent dimensions should
generate a reasonable nosology, as judged by physicians in our team.
Deﬁning disease features for prediction. Disease-speciﬁc features in our model
included a set of derivatives from disease prevalence curves and disease embedding.
Speciﬁcally, for heritability imputation (single-disease analysis), the curve-derived
set comprised a collection of disease-speciﬁc counts, which we normalized to 1 (as
deﬁned in Analysis B of Methods part 1), between ages 0 and 65 as well as to
cumulative counts. We deﬁned the cumulative count for age N as a sum of all
normalized counts from age 0 until the age N, inclusively. The embedding-derived
set included all 20 real-valued elements in the 20-dimensional embedding vector.
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We supplemented these two sets of features with a “biological system” label (a set
of 20 labels shown in Fig. 2a, plus the label “Other”), the gender bias, the carrier’s
mean age, and the disease onset age.
As for correlation imputation (two-disease analysis), because disease pairs were
involved, we used the mean and difference values of the normalized counts,
cumulative counts, and embedding elements of each pair. In essence, these
difference values captured disease-disease dissimilarities involving the comparison
of single-disease features, such as distances between prevalence curves and
between embeddings. Extending the one-disease supplemental features mentioned
above, we also introduced disease-disease dissimilarities in their assigned biological
system, in the gender bias, in the mean carrier age, and in the disease onset age.
For both single- and two-disease analyses, we also included categorical features to
differentiate our predicted estimates by data type used, mathematical model, and basic
information about the investigated cohorts (patient gender and country of origin). We
used ﬁve data type labels (“twin study,” “family study,” “family study using EHRs,”
“SNP-based study,” and “PRS-based study,” as categorical one-hot-encoded variables),
and six distinct labels to account for difference in mathematical models from
published estimates (“AE,” “ACE,” “PRS,” “SOLAR,” “GREML,” and “LDSC”).
All training datasets for heritability and correlation imputation are available at
https://github.com/jiagengjie/Estimating-Genetic-Parameters.
Analysis of disease onset age. For sex-speciﬁc heritability h2, through an
extensive literature search, we collected 1146 h2 estimates for 403 unique diseases,
but only 155 estimates for 68 unique diseases were gender-speciﬁc. These data were
then substantially enriched by a set of estimates obtained in this study. If multiple
estimates were available for a given disease and gender, we combined the estimates
using the inverse-variance weighting method.
For correlation analysis, to investigate associations between disease onset age
and the two metrics (diagnosis count and heritability), we applied Spearman’s ρ
statistic and computed their p-values using algorithm AS 89 (refs. 37,38) for the
identiﬁed ﬁve clusters, both jointly and individually.
We performed regression analyses to ﬁt linear models between disease onset age
and either disease prevalence or heritability. We used the Student’s t test to
determine whether the slope and intercept estimates signiﬁcantly differed from
zero. These results are reported in Figs. 3f–g, 4a–c, Supplementary Tables 2 and 3.
Analysis of shape-of-curve dissimilarity (Dsoc). Through an extensive literature
search, we gathered 812 estimates of genetic correlation rg and environmental cor-
relation re. We then used our imputation procedure to extend this set of estimates to
an exhaustive set of pairwise comparisons over approximately 500 diseases in total.
In a similar fashion, we performed regression analysis for intra- and inter-
category disease pairs to ﬁt models explaining Dsoc in terms of estimates of rg and
re. We determined the slope’s signiﬁcance and intercept estimates being different
from zero via Student’s t test. We report these results in Fig. 4d, Supplementary
Fig. 5 and Supplementary Data 6.
Model. For model training, we collected 1146 h2 estimates and 1947 corr estimates
from 234 individual publications (Supplementary Table 4 lists a few representative,
large-scale studies along with their key features, and the complete data can be
found in the upper rows of Supplementary Data 1 and 2). We experimented with a
few predictive methodologies, including generalized linear models (Lasso, Huber
regression, and ridge regression), kernel ridge regression, support vector regression,
and ensemble methods (random forest, AdaBoost random forest, and gradient
boosting regression). These algorithms all performed rather well, as evaluated on
1000 repeated runs (in each run, we randomly selected four-ﬁfths of the data for
training and one-ﬁfth for validation, see Table 1). Gradient boosting regression
performed the best (Table 1 and Fig. 3b–d) and is explained in more detail below.
Given a training dataset of known output and input pairs yi;Xif gN1 , the
algorithm’s goal is to obtain an approximation to the function F(X) that maps X to
y (denoted bFðXÞ), such that the expectation of a loss function Lðy; bFðXÞÞ is
minimized. The gradient boosting regression model utilizes an ensemble of
predictor regression trees33, built in a forward, stage-wise fashion to minimize a
differentiable squared-error function ðy  bFðXÞÞ2. The pseudo-code for this
computation is as follows:
F0 Xð Þ ¼ y
Form ¼ 1 toM do :
~yi ¼ yi  Fm1 Xið Þ; i ¼ 1;    ;N
ðρm; αmÞ ¼ argminρ;α
PN
i¼1
~yi  ρh Xi; αð Þ½ 2
Fm Xð Þ ¼ Fm1 Xð Þ þ ρmh X; αmð Þ
end For
where h(X;αm) and αm denote the base learners (regression trees) and the vector of
model parameters (split locations and means of tree terminals). The number of
trees M and the learning rate ρm are model hyperparameters, which we tuned to
200 and 0.1, respectively. We started with a model containing only the constant
function F0(X), and incrementally expanded it in the for-loop as shown above51.
Ultimately, we deployed this model to obtain estimates of h2 and corr, not only
for the complete spectrum of diseases and two sexes, but also for various data types
and modeling assumptions (see Supplementary Data 1 and 2 for the complete
collection of estimates).
Data availability
We have launched a searchable web application for researchers to explore and compare
sex-and-country-stratiﬁed prevalence curves for over 500 diseases. https://gjia.shinyapps.
io/disease_curves/.
The license of MarketScan databases is available to purchase by Federal, nonproﬁt,
academic, pharmaceutical, and other researchers. Access to the data is contingent on
completing a data use agreement and purchasing the needed license. More information
about licensing the MarketScan databases can be found at https://www.ibm.com/us-en/
marketplace/marketscan-research-databases.
Access to individual-level Denmark data is governed by Danish authorities, including
the Danish Data Protection Agency, the Danish Health Data Authority, the Ethical
Committee, and Statistics Denmark. Researchers at Danish research institutions must
obtain the relevant approval and data before initiating relevant scientiﬁc projects.
International researchers may gain data access if supervised by a Danish research
institution that has needed approval and data access.
The study has been approved by the ethical review board in the Stockholm county
(DNR 2018/2153-31). Data storage and access is compliant with local laws and
regulations.
All other data contained in the article and in its supplementary information are
available upon request.
Code availability
All codes, which compared various modeling algorithms for heritability and correlation
imputation, and thus generated the results shown in Table 1, are available at https://
github.com/jiagengjie/Estimating-Genetic-Parameters.
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